statistiche ricercatore

Continente	#
NA - Nord America	1.075
AS - Asia	367
EU - Europa	298
SA - Sud America	71
AF - Africa	18
Continente sconosciuto - Info sul continente non disponibili	9
OC - Oceania	1
Totale	1.839

Nazione	#
US - Stati Uniti d'America	1.051
SG - Singapore	115
IT - Italia	80
CN - Cina	61
BR - Brasile	50
GB - Regno Unito	46
VN - Vietnam	46
BD - Bangladesh	42
HK - Hong Kong	41
DE - Germania	39
SE - Svezia	34
FI - Finlandia	22
IE - Irlanda	18
RU - Federazione Russa	18
IN - India	13
CA - Canada	11
FR - Francia	11
ID - Indonesia	8
KR - Corea	7
AR - Argentina	6
BG - Bulgaria	6
JP - Giappone	6
PL - Polonia	6
ZA - Sudafrica	5
CO - Colombia	4
EC - Ecuador	4
IQ - Iraq	4
MX - Messico	4
MY - Malesia	4
PK - Pakistan	4
TR - Turchia	4
BE - Belgio	3
MA - Marocco	3
NL - Olanda	3
AZ - Azerbaigian	2
BO - Bolivia	2
CR - Costa Rica	2
DZ - Algeria	2
GP - Guadalupe	2
KE - Kenya	2
LT - Lituania	2
PH - Filippine	2
SI - Slovenia	2
SV - El Salvador	2
TN - Tunisia	2
UY - Uruguay	2
VE - Venezuela	2
AL - Albania	1
AT - Austria	1
BW - Botswana	1
CI - Costa d'Avorio	1
CW - ???statistics.table.value.countryCode.CW???	1
ES - Italia	1
GR - Grecia	1
GT - Guatemala	1
HN - Honduras	1
HR - Croazia	1
HU - Ungheria	1
JM - Giamaica	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LB - Libano	1
MD - Moldavia	1
ML - Mali	1
MN - Mongolia	1
NZ - Nuova Zelanda	1
PE - Perù	1
PS - Palestinian Territory	1
QA - Qatar	1
SA - Arabia Saudita	1
SC - Seychelles	1
TH - Thailandia	1
UA - Ucraina	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.832

Nome	#
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis	380
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy	342
Lifestyle intervention on body weight and physical activity in patients with breast cancer can reduce the risk of death in obese women: The EMILI study	329
Hereditary ovarian cancers: State of the art	292
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials	275
PARP inhibitors for the treatment of ovarian cancer	221
Totale	1.839

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	93	0	0	0	0	3	13	2	4	14	16	28	13
2022/2023	162	16	26	9	19	12	22	2	12	31	3	4	6
2023/2024	83	2	3	6	15	21	6	9	5	0	4	4	8
2024/2025	297	7	0	4	17	59	43	29	18	49	13	21	37
2025/2026	590	33	4	37	58	76	41	66	33	42	63	70	67
2026/2027	178	22	44	43	57	12	0	0	0	0	0	0	0
Totale													1.839